共 482 条
- [1] Kalimutho M(2015)Targeted therapies for triple-negative breast Cancer: combating a stubborn disease Trends Pharmacol Sci 36 822-846
- [2] Parsons K(2012)Complexity in the signaling network: insights from the use of targeted inhibitors in cancer therapy Genes Dev 26 641-650
- [3] Mittal D(2013)Cancer drug resistance: an evolving paradigm Nat Rev Cancer 13 714-726
- [4] Lopez JA(2009)Resistance to targeted therapies: refining anticancer therapy in the era of molecular oncology Clin Cancer Res 15 7471-7478
- [5] Srihari S(2014)Kinome profiling reveals breast cancer heterogeneity and identifies targeted therapeutic opportunities for triple negative breast cancer Oncotarget 5 3145-3158
- [6] Khanna KK(2014)Rationale for targeting the Ras/MAPK pathway in triple-negative breast cancer Discov Med 17 275-283
- [7] Logue JS(2015)Activation of KRAS promotes the mesenchymal features of basal-type breast cancer Exp Mol Med 47 e137-976
- [8] Morrison DK(2009)Reciprocal effects of STAT5 and STAT3 in breast cancer Mol Cancer Res 7 966-811
- [9] Holohan C(2012)JAK2/STAT5 inhibition circumvents resistance to PI3K/mTOR blockade: a rationale for cotargeting these pathways in metastatic breast cancer Cancer Cell 22 796-2848
- [10] Van Schaeybroeck S(2016)Triple-negative breast cancers with amplification of JAK2 at the 9p24 locus demonstrate JAK2-specific dependence Sci Transl Med 8 334ra353-9929